Literature DB >> 8774127

Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution.

T Marchbank1, R Chinery, A M Hanby, R Poulsom, G Elia, R J Playford.   

Abstract

Pancreatic secretory trypsin inhibitor (PSTI) is a potent serine protease inhibitor that prevents excessive digestion of the gastrointestinal mucus but may also directly affect epithelial function. We therefore examined the distribution of PSTI in the human adult and fetus using immunohistochemistry and in situ hybridization and examined its effects on cell proliferation and migration in vitro. PSTI peptide and mRNA were found in the exocrine pancreas, mucus-producing cells of the normal gastrointestinal tract, acinar component of the normal breast, and surface epithelial cells at the edge of benign gastric ulcers. Peptide, but not message, was identified in the renal proximal tubule, probably reflecting reabsorption of filtered peptide. Purified human PSTI did not affect proliferation of the human colonic cell line HT-29 but caused a threefold increase in the rate of migration in an in vitro wounding model of restitution. This effect was inhibited by co-administering a PSTI-neutralizing antibody, a transforming growth factor-beta-neutralizing antibody, or an epidermal growth factor receptor-blocking antibody. As PSTI is widely distributed in several human organ systems and stimulates cell migration in vitro, we conclude that PSTI is likely to have additional roles to that of preserving the gastrointestinal mucous layer from excessive digestion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774127      PMCID: PMC1861739     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa.

Authors:  T Shibata; M Ogawa; N Takata; K Matsuda; T Niinobu; K Uda; C Wakasugi; T Mori
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-02

3.  Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family.

Authors:  L A Scheving
Journal:  Arch Biochem Biophys       Date:  1983-10-15       Impact factor: 4.013

4.  Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells.

Authors:  T C Freeman; B J Curry; J Calam; J R Woodburn
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

5.  Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues.

Authors:  M Fukayama; Y Hayashi; M Koike; M Ogawa; G Kosaki
Journal:  J Histochem Cytochem       Date:  1986-02       Impact factor: 2.479

6.  Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA.

Authors:  T Yamamoto; Y Nakamura; J Nishide; M Emi; M Ogawa; T Mori; K Matsubara
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

7.  Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.

Authors:  S Fukuoka; T Fushiki; Y Kitagawa; E Sugimoto; K Iwai
Journal:  Biochem Biophys Res Commun       Date:  1987-06-15       Impact factor: 3.575

8.  Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat.

Authors:  R Chinery; R J Playford
Journal:  Clin Sci (Lond)       Date:  1995-04       Impact factor: 6.124

9.  The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study.

Authors:  P V Senior; D R Critchley; F Beck; R A Walker; J M Varley
Journal:  Development       Date:  1988-11       Impact factor: 6.868

10.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.

Authors:  Y Sato; D B Rifkin
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  18 in total

Review 1.  Clinical relevance of proteinase activated receptors (pars) in the gut.

Authors:  N Vergnolle
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  [-215G>A; IVS3+2T>C] mutation in the SPINK1 gene causes exon 3 skipping and loss of the trypsin binding site.

Authors:  K Kume; A Masamune; K Kikuta; T Shimosegawa
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype.

Authors:  Joelle M-J Romac; Masaki Ohmuraya; Cathy Bittner; M Faraz Majeed; Steven R Vigna; Jianwen Que; Brian E Fee; Thomas Wartmann; Ken-ichi Yamamura; Rodger A Liddle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-28       Impact factor: 4.052

4.  Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.

Authors:  Maija Piekkala; Jaana Hagström; Maarit Tanskanen; Risto Rintala; Caj Haglund; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.

Authors:  Tania Marchbank; Asif Mahmood; Anthony J Fitzgerald; Jan Domin; Matt Butler; Robert A Goodlad; George Elia; Helen M Cox; David A van Heel; Subrata Ghosh; Raymond J Playford
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

6.  Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development.

Authors:  Jun Wang; Masaki Ohmuraya; Masahiko Hirota; Hideo Baba; Gang Zhao; Motohiro Takeya; Kimi Araki; Ken-ichi Yamamura
Journal:  Histochem Cell Biol       Date:  2008-04-02       Impact factor: 4.304

Review 7.  Modulation of visceral pain and inflammation by protease-activated receptors.

Authors:  Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

8.  Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.

Authors:  Christine P Diggle; Sheena Cruickshank; Jonathon D Olsburgh; Stephanie Pellegrin; Barbara Smith; Rosamonde E Banks; Peter J Selby; Margaret A Knowles; Jennifer Southgate; Patricia Harnden
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.

Authors:  Hatem A El-mezayen; Fatheya M Metwally; Hossam Darwish
Journal:  Tumour Biol       Date:  2013-11-13

10.  Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform.

Authors:  Tore Midtvedt; Eugene Zabarovsky; Elisabeth Norin; Johan Bark; Rinat Gizatullin; Vladimir Kashuba; Olle Ljungqvist; Veronika Zabarovska; Roland Möllby; Ingemar Ernberg
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.